These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30633590)

  • 1. The impact of perampanel and targeting AMPA transmission on anti-seizure drug discovery.
    Lattanzi S; Striano P
    Expert Opin Drug Discov; 2019 Mar; 14(3):195-197. PubMed ID: 30633590
    [No Abstract]   [Full Text] [Related]  

  • 2. The discovery and development of perampanel for the treatment of epilepsy.
    Hanada T
    Expert Opin Drug Discov; 2014 Apr; 9(4):449-58. PubMed ID: 24559052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanism.
    Kato AS; Burris KD; Gardinier KM; Gernert DL; Porter WJ; Reel J; Ding C; Tu Y; Schober DA; Lee MR; Heinz BA; Fitch TE; Gleason SD; Catlow JT; Yu H; Fitzjohn SM; Pasqui F; Wang H; Qian Y; Sher E; Zwart R; Wafford KA; Rasmussen K; Ornstein PL; Isaac JT; Nisenbaum ES; Bredt DS; Witkin JM
    Nat Med; 2016 Dec; 22(12):1496-1501. PubMed ID: 27820603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perampanel and decanoic acid show synergistic action against AMPA receptors and seizures.
    Augustin K; Williams S; Cunningham M; Devlin AM; Friedrich M; Jayasekera A; Hussain MA; Holliman D; Mitchell P; Jenkins A; Chen PE; Walker MC; Williams RSB
    Epilepsia; 2018 Nov; 59(11):e172-e178. PubMed ID: 30324610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent models.
    Zwart R; Sher E; Ping X; Jin X; Sims JR; Chappell AS; Gleason SD; Hahn PJ; Gardinier K; Gernert DL; Hobbs J; Smith JL; Valli SN; Witkin JM
    J Pharmacol Exp Ther; 2014 Oct; 351(1):124-33. PubMed ID: 25027316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perampanel (Fycompa) for epilepsy.
    Med Lett Drugs Ther; 2014 Feb; 56(1435):9-10. PubMed ID: 24662975
    [No Abstract]   [Full Text] [Related]  

  • 7. Perampanel in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.
    Strzelczyk A; Willems LM; Willig S; Rosenow F; Bauer S
    Expert Rev Clin Pharmacol; 2015; 8(6):733-40. PubMed ID: 26436331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of perampanel-induced delirium in a patient with symptomatic epilepsy.
    Takeshima M; Ishikawa H; Ono T; Kanbayashi T; Shimizu T
    Seizure; 2018 May; 58():154-155. PubMed ID: 29709827
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical pharmacology profile of the new antiepileptic drug perampanel: A novel noncompetitive AMPA receptor antagonist.
    Patsalos PN
    Epilepsia; 2015 Jan; 56(1):12-27. PubMed ID: 25495693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
    Twele F; Bankstahl M; Klein S; Römermann K; Löscher W
    Neuropharmacology; 2015 Aug; 95():234-42. PubMed ID: 25839899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and impact on cognitive functions and quality of life of perampanel as first add-on therapy in patients with epilepsy: A retrospective study.
    Rea R; Traini E; Renna R; Pagliuca F; Pezzella M; Pagliuca M
    Epilepsy Behav; 2019 Sep; 98(Pt A):139-144. PubMed ID: 31374469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with perampanel: focus on psychiatric adverse effects.
    Coyle H; Clough P; Cooper P; Mohanraj R
    Epilepsy Behav; 2014 Dec; 41():193-6. PubMed ID: 25461214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perampanel, a novel, non-competitive, selective AMPA receptor antagonist as adjunctive therapy for treatment-resistant partial-onset seizures.
    Rektor I
    Expert Opin Pharmacother; 2013 Feb; 14(2):225-35. PubMed ID: 23259931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of calcium-permeable and calcium-impermeable AMPA receptors by perampanel in rat brain neurons.
    Barygin OI
    Neurosci Lett; 2016 Oct; 633():146-151. PubMed ID: 27663136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro.
    Lange F; Weßlau K; Porath K; Hörnschemeyer MF; Bergner C; Krause BJ; Mullins CS; Linnebacher M; Köhling R; Kirschstein T
    PLoS One; 2019; 14(2):e0211644. PubMed ID: 30716120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of perampanel in children and adults with various epilepsy syndromes: A single-center postmarketing study.
    Singh K; Shah YD; Luciano D; Friedman D; Devinsky O; Kothare SV
    Epilepsy Behav; 2016 Aug; 61():41-45. PubMed ID: 27300147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term tolerability, safety and efficacy of adjunctive perampanel in the open-label, dose-ascending Study 231 and extension Study 233 in Japanese patients with epilepsy.
    Usui N; Akamatsu N; Nakasato N; Ohnishi A; Kaneko S; Hiramatsu H; Saeki K; Miyagishi H; Inoue Y
    Seizure; 2018 Nov; 62():26-32. PubMed ID: 30267941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AMPA receptor antagonist perampanel is a new hope in the treatment for epilepsy.
    El Desoky ES
    Fundam Clin Pharmacol; 2014 Oct; 28(5):473-80. PubMed ID: 24750493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the pharmacotherapy of epilepsy: brivaracetam and perampanel as broad-spectrum antiseizure drugs for the treatment of epilepsies and status epilepticus.
    Willems LM; Bauer S; Rosenow F; Strzelczyk A
    Expert Opin Pharmacother; 2019 Oct; 20(14):1755-1765. PubMed ID: 31264486
    [No Abstract]   [Full Text] [Related]  

  • 20. Perampanel: a new agent for adjunctive treatment of partial seizures.
    Faulkner MA
    Am J Health Syst Pharm; 2014 Feb; 71(3):191-8. PubMed ID: 24429011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.